Credit Suisse’s Rapid Micro Biosystems RPID Stock Holding History

Credit Suisse’s Portfolio RPID Stock Details RPID Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-8	Closed	–	–	4248
2022 Q2	$0	Buy	+8	New	+$37	﹤0.01%	4254

Other funds holding RPID

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

KLM

Kennedy Lewis Management New York $21.9M AUM 12.46% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AWGLSCP

ABG-WTT Global Life Science Capital Partners Central, Hong Kong, Hong Kong $12.3M AUM 3.13% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

GCM

Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Credit Suisse's RPID Position: Q3 2022 in Review

Credit Suisse sold out of Rapid Micro Biosystems (RPID) in Q3 2022, closing a stake of 8 shares.

Credit Suisse first reported a position in RPID in Q2 2022 and held it in 1 quarter. The position peaked at $0 in Q2 2022. 53 funds tracked by Wall St. Rank hold RPID as of Q3 2022.

Credit Suisse reported no remaining Rapid Micro Biosystems position as of Q3 2022 after selling out during the quarter.
Credit Suisse sold 8 Rapid Micro Biosystems shares in Q3 2022.
Credit Suisse first reported a position in Rapid Micro Biosystems in Q2 2022 and held it in 1 quarter.
Credit Suisse's Rapid Micro Biosystems position peaked at $0 in Q2 2022.
53 funds tracked by Wall St. Rank held Rapid Micro Biosystems as of Q3 2022.

Based on Credit Suisse's 13F filing for Q3 2022, filed 10 Nov 2022.